Skip to main content
main-content
Erschienen in: Clinical and Experimental Nephrology 3/2022

08.11.2021 | COVID-19 | Letter to the editor Zur Zeit gratis

Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study

verfasst von: Masatoshi Matsunami, Tomo Suzuki, Toshiki Terao, Hiroshi Kuji, Kosei Matsue

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor
Literatur
1.
Zurück zum Zitat Stumpf J, Siepmann T, Lindner T, Karger C, Schwöbel J, Anders L, et al. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9:100178. CrossRef Stumpf J, Siepmann T, Lindner T, Karger C, Schwöbel J, Anders L, et al. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9:100178. CrossRef
2.
Zurück zum Zitat Marinaki S, Adamopoulos S, Degiannis D, Roussos S, Pavlopoulou ID, Hatzakis A, et al. Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients. Am J Transplant. 2021;21(8):2913–5. CrossRef Marinaki S, Adamopoulos S, Degiannis D, Roussos S, Pavlopoulou ID, Hatzakis A, et al. Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients. Am J Transplant. 2021;21(8):2913–5. CrossRef
3.
Zurück zum Zitat Broseta JJ, Rodríguez-Espinosa D, Rodríguez N, Mosquera MDM, Marcos M, Egri N, et al. Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients. Am J Kidney Dis. 2021;78(4):571–81. CrossRef Broseta JJ, Rodríguez-Espinosa D, Rodríguez N, Mosquera MDM, Marcos M, Egri N, et al. Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients. Am J Kidney Dis. 2021;78(4):571–81. CrossRef
4.
Zurück zum Zitat Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021;99(6):1498–500. CrossRef Benotmane I, Gautier-Vargas G, Cognard N, Olagne J, Heibel F, Braun-Parvez L, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021;99(6):1498–500. CrossRef
5.
Zurück zum Zitat Agur T, Ben-Dor N, Goldman S, Lichtenberg S, Herman-Edelstein M, Yahav D, et al. Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study. Nephrol Dial Transplant. 2021;36(7):1347–9. CrossRef Agur T, Ben-Dor N, Goldman S, Lichtenberg S, Herman-Edelstein M, Yahav D, et al. Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study. Nephrol Dial Transplant. 2021;36(7):1347–9. CrossRef
Metadaten
Titel
Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study
verfasst von
Masatoshi Matsunami
Tomo Suzuki
Toshiki Terao
Hiroshi Kuji
Kosei Matsue
Publikationsdatum
08.11.2021
Verlag
Springer Singapore
Schlagwort
COVID-19
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2022
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-021-02156-y

Weitere Artikel der Ausgabe 3/2022

Clinical and Experimental Nephrology 3/2022 Zur Ausgabe

Corona-Update

Die aktuelle Entwicklung im Überblick: Nachrichten, Webinare, Übersichtsarbeiten.